The Medical Device Regulation (MDR) started in May 2017 to replace the older Medical Device Directive (MDD). It aims to improve the safety, quality, and performance of medical devices in the European Union. The regulation has tougher rules for clinical data, classification, documentation, and monitoring after devices are on the market. It covers all medical devices, from simple bandages to implantable devices with higher risk.
One big change in the MDR is that many devices got reclassified based on risk. Some devices that were once seen as low risk are now in higher risk groups. This means these devices need more detailed checks and stricter controls.
U.S. medical device makers who sell products to Europe must apply to European Notified Bodies. These groups check if the devices follow MDR rules. The checks under MDR are tougher than before.
Some devices that used to be low risk now need more testing. For example, a device that was Class I before might now be Class IIa or IIb. Manufacturers need to provide more proof, like clinical trials and safety data, to show their devices meet the new rules.
This change means U.S. makers have to prepare more paperwork and face longer reviews. It could slow down product releases and cost more money.
The MDR set deadlines for devices certified under the old rules. Manufacturers had to apply by May 26, 2024, to keep using old certificates during the changeover. Higher-risk devices must fully follow MDR by December 31, 2027. Other devices need to comply by December 31, 2028.
These deadlines push U.S. makers to update their quality systems and documents quickly. Missing deadlines could mean products are banned from Europe, causing money loss and hurting reputations.
MDR requires manufacturers to have a Quality Management System that fits its rules. This means better documentation, more audits, and following new technical standards. The system covers device design, production, performance after sale, and risk handling.
For U.S. companies, this may mean changing current processes and investing in new quality controls. Having a good QMS is important for getting certified and selling in Europe.
If manufacturers want to change an old device’s design, use, or materials during the transition, they must get approval first. They have to check with their Notified Body before making major changes. This means companies must plan carefully to meet the rules and still improve products.
This adds difficulty for U.S. makers who want to update devices. They must think about rules and timelines when making changes.
MDR brought more Notified Bodies to check devices and certificates. But these bodies now work in narrower areas. This means they do more detailed reviews but might have less capacity, causing delays.
U.S. manufacturers need to work closely with these bodies to avoid waiting and delays. They also must prepare well for increased inspections.
Many U.S. medical offices use devices made in the U.S. and other countries. MDR’s strict rules can affect how easy it is to get these devices, how much they cost, and how fast new products come.
U.S. medical providers might see shortages or delays if manufacturers stop or slow production to meet MDR rules. This is more likely for higher-risk devices. Practices should plan for possible supply problems and manage inventory carefully.
Following the MDR means higher costs for making devices because of extra tests, paperwork, and quality checks. These costs may raise prices, affecting budgets for U.S. medical offices.
Administrators and IT staff in medical offices might need to track device certifications and compliance more closely, because MDR requires more monitoring after devices are sold. Keeping device information updated helps with patient safety and meeting rules.
MDR’s complex rules mean that healthcare and manufacturers must use tools to help work faster and more accurately. Artificial intelligence (AI) and automation are helpful here.
AI can help manufacturers organize, update, and check all the documents needed under MDR. AI can find mistakes, track changes, and suggest fixes more quickly than people can.
Processes like managing clinical reports or post-market data are easier with AI. It also helps prepare for audits.
Automation tools like AI chatbots and scheduling software help manufacturers stay in touch with Notified Bodies. They can send paperwork on time and respond quickly to questions. This reduces delays in certification.
AI-powered phone systems and automation tools help office staff handle patient calls and device questions. Some companies offer AI systems that manage calls and appointment booking. These tools let healthcare workers focus on patients without distractions.
By automating routine tasks and giving real-time device info, AI helps with buying, maintenance, and inventory decisions.
AI-based automation can track device recalls, alerts, and updates. Connecting these tools to Electronic Health Records (EHRs) or inventory software helps manage device safety better.
For U.S. medical centers importing devices from Europe, automated systems can help follow both MDR and FDA rules by gathering and reporting data efficiently.
Curtis Riley, who leads regulatory compliance at Intertek Medical Notified Body, stresses that cooperation among everyone involved is important for device safety. With 20 years of experience, he shows the detailed work needed to follow MDR—from checking documents to clinical reviews.
Intertek and other Notified Bodies watch medical devices continuously and provide updated guidance as MDR changes. U.S. manufacturers and healthcare providers should stay updated on rules and certifications by using expert help and industry news.
The Medical Device Regulation changes device safety and rules worldwide. Though it is made for the European Union, it also affects U.S. makers, medical practice managers, owners, and IT staff. They have to change how they handle device classes, documents, quality systems, and monitoring after sale.
Knowing how MDR works and using AI tools for compliance and office tasks can help U.S. healthcare organizations stay efficient, follow rules, and handle future changes.
The MDR is a regulatory framework in the European Union enacted in May 2017 to ensure the safety and performance of medical devices. It replaced the previous Medical Device Directive (MDD) and aims to address challenges in the medical device industry.
Key changes include the reclassification of devices based on risk, necessitating more rigorous conformity assessments, increased documentation requirements, and the need for clinical data to support the safety and performance of devices.
Manufacturers faced challenges such as the readiness of Notified Bodies, industry preparedness, and the impact of the COVID-19 pandemic, which led to extended deadlines for compliance.
‘Legacy devices’ are those certified under the previous MDD. Manufacturers must submit applications to Notified Bodies to extend the validity of their MDD certificates while committing to transition to MDR certification.
Key deadlines include submitting applications to Notified Bodies by May 26, 2024, and finalizing agreements by September 26, 2024. Compliance extensions are set for December 31, 2027, for higher-risk devices and December 31, 2028, for other devices.
The MDR requires manufacturers to maintain a compliant quality management system (QMS) that aligns with new regulations, involving rigorous documentation, regular audits, and adherence to updated standards.
Significant changes to the design, intended use, or materials of legacy devices during the extension period may require a new conformity assessment under the MDR. Manufacturers must consult their Notified Body prior to making any substantial changes.
The number of Notified Bodies has increased, albeit with more specific and narrow scopes, enhancing the capacity to address the influx of applications and ensuring timely certification processes.
Notified Bodies are responsible for issuing necessary certifications and conducting ongoing surveillance to ensure compliance. They also provide guidance and support to manufacturers during the transition to the MDR.
The MDR aims to foster a more robust regulatory environment, enhancing the safety and performance of medical devices in the EU market through collaboration between Notified Bodies, manufacturers, and regulatory authorities.
Simbo is using AI agents to automate all phone related workflows. Connect now to know more.
Schedule AI Agents Demo Now© Since 2019, Simbo AI.
